• Response After Single Treatment with Canakinumab Predicts Which Patients Will Benefit Most

    8 days ago - By BWH

    New analysis from CANTOS finds that measuring hsCRP levels after one dose of canakinumab can identify individuals likely to see greatest improvements from continued treatment.
    Read more ...